Analysts have raised the fair value target for Moelis from $78.60 to $80.00. This reflects modest improvements in revenue growth expectations, along with adjustments for a slightly higher discount rate and a lower projected future price-earnings ratio.
What's in the News
- Moelis completed the repurchase of 27,028 shares between April 1 and June 30, 2025, totaling $1.43 million (Key Developments).
- Since announcing its buyback on February 6, 2019, Moelis has repurchased a total of 3,146,784 shares. This represents 5.29 percent of its outstanding shares and an aggregate value of $137.83 million (Key Developments).
Valuation Changes
- The Fair Value Target has risen slightly from $78.60 to $80.00.
- The Discount Rate increased marginally from 8.12% to 8.14%.
- Revenue Growth expectations edged up from 15.29% to 15.38%.
- The Net Profit Margin forecast dipped slightly from 17.99% to 17.95%.
- The Future P/E Ratio estimate declined from 24.20x to 22.79x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.